These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 26548726)

  • 1. Topical lipophilic epigallocatechin-3-gallate on herpes labialis: a phase II clinical trial of AverTeaX formula.
    Zhao M; Zheng R; Jiang J; Dickinson D; Fu B; Chu TC; Lee LH; Pearl H; Hsu S
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Dec; 120(6):717-24. PubMed ID: 26548726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can clinical trials requiring frequent participant contact be conducted over the Internet? Results from an online randomized controlled trial evaluating a topical ointment for herpes labialis.
    Formica M; Kabbara K; Clark R; McAlindon T
    J Med Internet Res; 2004 Feb; 6(1):e6. PubMed ID: 15111272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penciclovir cream for the treatment of herpes simplex labialis. A randomized, multicenter, double-blind, placebo-controlled trial. Topical Penciclovir Collaborative Study Group.
    Spruance SL; Rea TL; Thoming C; Tucker R; Saltzman R; Boon R
    JAMA; 1997 May; 277(17):1374-9. PubMed ID: 9134943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effect of 1,5-pentanediol for herpes simplex labialis: a randomized, double-blind, placebo-controlled clinical trial.
    Busch R; Graubaum HJ; Gruenwald J; Faergemann J
    Adv Ther; 2009 Jul; 26(7):719-27. PubMed ID: 19649583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Balm mint extract (Lo-701) for topical treatment of recurring herpes labialis.
    Koytchev R; Alken RG; Dundarov S
    Phytomedicine; 1999 Oct; 6(4):225-30. PubMed ID: 10589440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind, placebo-controlled study of topical tetracaine in the treatment of herpes labialis.
    Kaminester LH; Pariser RJ; Pariser DM; Weiss JS; Shavin JS; Landsman L; Haines HG; Osborne DW
    J Am Acad Dermatol; 1999 Dec; 41(6):996-1001. PubMed ID: 10570387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of a topical herbal and mineral formulation (Dynamiclear) for the treatment of herpes simplex labialis in the community setting: study protocol for a randomised, double-blind placebo-controlled trial.
    Armour M; Semprini A; Ee C; MacCullagh L; Shortt N
    BMJ Open; 2020 Jan; 10(1):e031876. PubMed ID: 31932389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A proprietary topical preparation containing EGCG-stearate and glycerin with inhibitory effects on herpes simplex virus: case study.
    Zhao M; Jiang J; Zheng R; Pearl H; Dickinson D; Fu B; Hsu S
    Inflamm Allergy Drug Targets; 2012 Oct; 11(5):364-8. PubMed ID: 22583482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II clinical trial of a natural formulation containing tea catechins for xerostomia.
    De Rossi SS; Thoppay J; Dickinson DP; Looney S; Stuart M; Ogbureke KU; Hsu S
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Oct; 118(4):447-454.e3. PubMed ID: 25240992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: A multicenter, randomized, placebo-controlled trial.
    Sacks SL; Thisted RA; Jones TM; Barbarash RA; Mikolich DJ; Ruoff GE; Jorizzo JL; Gunnill LB; Katz DH; Khalil MH; Morrow PR; Yakatan GJ; Pope LE; Berg JE;
    J Am Acad Dermatol; 2001 Aug; 45(2):222-30. PubMed ID: 11464183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of herpes labialis with topical acyclovir.
    Fiddian AP; Yeo JM; Stubbings R; Dean D
    Br Med J (Clin Res Ed); 1983 May; 286(6379):1699-701. PubMed ID: 6405939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Green tea catechins prevent low-density lipoprotein oxidation via their accumulation in low-density lipoprotein particles in humans.
    Suzuki-Sugihara N; Kishimoto Y; Saita E; Taguchi C; Kobayashi M; Ichitani M; Ukawa Y; Sagesaka YM; Suzuki E; Kondo K
    Nutr Res; 2016 Jan; 36(1):16-23. PubMed ID: 26773777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical ether and herpes simplex labialis.
    Guinan ME; MacCalman J; Kern ER; Overall JC; Spruance SL
    JAMA; 1980 Mar; 243(10):1059-61. PubMed ID: 6243714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical application of penciclovir cream for the treatment of herpes simplex facialis/labialis: a randomized, double-blind, multicentre, aciclovir-controlled trial.
    Lin L; Chen XS; Cui PG; Wang JB; Guo ZP; Lu NZ; Bi ZG; Jia H; Yang XY;
    J Dermatolog Treat; 2002 Jun; 13(2):67-72. PubMed ID: 12060504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of the clinical activity of a gel combining monocaprin and doxycycline: a novel treatment for herpes labialis.
    Skulason S; Holbrook WP; Thormar H; Gunnarsson GB; Kristmundsdottir T
    J Oral Pathol Med; 2012 Jan; 41(1):61-7. PubMed ID: 21535163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical undecylenic acid for herpes simplex labialis: a multicenter, placebo-controlled trial.
    Shafran SD; Sacks SL; Aoki FY; Tyrrell DL; Schlech WF; Mendelson J; Rosenthal D; Gill MJ; Bader RL; Chang I
    J Infect Dis; 1997 Jul; 176(1):78-83. PubMed ID: 9207352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, placebo-controlled study to test the efficacy of topical 2-hydroxypropyl-Beta-cyclodextrin in the prophylaxis of recurrent herpes labialis.
    Senti G; Iannaccone R; Graf N; Felder M; Tay F; Kündig T
    Dermatology; 2013; 226(3):247-52. PubMed ID: 23816977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical iontophoretic administration of acyclovir for the episodic treatment of herpes labialis: a randomized, double-blind, placebo-controlled, clinic-initiated trial.
    Morrel EM; Spruance SL; Goldberg DI;
    Clin Infect Dis; 2006 Aug; 43(4):460-7. PubMed ID: 16838235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized clinical trial on the treatment of oral herpes with topical zinc oxide/glycine.
    Godfrey HR; Godfrey NJ; Godfrey JC; Riley D
    Altern Ther Health Med; 2001; 7(3):49-56. PubMed ID: 11347285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of recurrent herpes simplex labialis with topical butylated hydroxytoluene.
    Freeman DJ; Wenerstrom G; Spruance SL
    Clin Pharmacol Ther; 1985 Jul; 38(1):56-9. PubMed ID: 2988845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.